Hantavirus (HTV) long-peptide vaccine
A technology of Hantavirus and virus antigen, applied in the field of long peptide vaccine of Hantavirus, can solve the problems of weakening the immune effect of the vaccine, and achieve the effects of simple and easy preparation method, strong immunogenicity and high safety
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0029] Example. Immunogenicity of HTNV long peptide compositions
[0030] 1. Materials and Methods
[0031] 1.1 Mice: BALB / c mice aged 6–8 weeks were purchased from the Animal Experiment Center of Lanzhou General Hospital of Lanzhou Military Region.
[0032]1.2 Peptides: According to the N nucleoprotein and Gn / Gc glycoprotein sequences of HTNV 76-118 strain, SEOV R22 strain, and DOBV Slo / Af-BER strain, as well as the immunodominant regions with dense T and B cell epitopes published in the literature, design and Synthetic HTNV long peptide was used as the antigenic component of the vaccine. N nucleoprotein is the most conserved structural protein in HTV, and it is also the main target for virus-specific T cell recognition. Its T cell epitope is mainly located in the 115–429 region of N nucleoprotein. In summary, 17 peptides covering the region of HTNV N110–429 were designed, including HTNV N110–136, HTNV N124–158, HTNV N144–169, HTNV N155–189, HTNV N175–200, HTNV N191–225 , ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com